/OHI
OHI Stock - Omega Healthcare Investors, Inc.
Real Estate|REIT - Healthcare FacilitiesNYSE
$43.97-1.21%
$0.54 (-1.21%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.67
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).63
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.98
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+6.4%upside
Target: $46.78
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OHI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$43.53 – $44.41
TARGET (TP)$46.80
STOP LOSS$40.45
RISK/REWARD1:0.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.55
52W High$46.36
52W Low$35.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.05B | $949.74M | $878.24M | $1.06B | $892.38M |
| Gross Profit | $1.04B | $934.72M | $862.74M | $1.05B | $880.07M |
| Gross Margin | 98.6% | 98.4% | 98.2% | 98.8% | 98.6% |
| Operating Income | $659.66M | $488.97M | $392.28M | $566.17M | $452.25M |
| Net Income | $406.33M | $242.18M | $426.93M | $416.74M | $159.33M |
| Net Margin | 38.6% | 25.5% | 48.6% | 39.2% | 17.9% |
| EPS | $1.57 | $1.04 | $1.81 | $1.76 | $0.70 |
Company Overview
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
10
42%
Hold / Neutral
12
50%
Sell / Underperform
2
8%
Analyst Consensus🔴 Bearish
10 Bullish14 Neutral/Bearish
Price Targets
$36
Average Target
↓ 18.5% Downside
Now
$25
Low
$36
Average
$50
High
Based on 29 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 18th 2025 | UBS | Initiation | Buy | $50 |
| October 1st 2025 | Cantor Fitzgerald | Initiation | Overweight | $50 |
| July 14th 2025 | Wells Fargo | Upgrade | Overweight | $41 |
| March 27th 2025 | Wells Fargo | Downgrade | Equal Weight | $39← $41 |
| December 9th 2024 | BMO Capital Markets | Upgrade | Outperform | $45 |
| October 31st 2024 | Exane BNP Paribas | Upgrade | Outperform | $49 |
| October 18th 2024 | Berenberg | Initiation | Buy | $45 |
| July 25th 2024 | Mizuho | Downgrade | Neutral | $35← $34 |
| March 22nd 2024 | Citigroup | Upgrade | Buy | $35← $32 |
| February 26th 2024 | Wells Fargo | Upgrade | Overweight | $35← $31 |
| February 8th 2024 | Exane BNP Paribas | Upgrade | Neutral | $30 |
| January 30th 2024 | Deutsche Bank | Initiation | Buy | $36 |
| January 16th 2024 | BofA Securities | Downgrade | Neutral | $31← $33 |
| November 6th 2023 | Exane BNP Paribas | Downgrade | Underperform | - |
| October 11th 2023 | Exane BNP Paribas | Initiation | Neutral | $36 |
Earnings History & Surprises
OHIBeat Rate
72%
Last 18 quarters
Avg Surprise
+14.6%
EPS vs Estimate
Beats / Misses
13/2
3 met exactly
Latest EPS
$0.79
Q4 2025
EPS Surprise History
Q1 24
+1.5%
$0.68vs$0.67
Q2 24
+4.6%
$0.68vs$0.65
Q3 24
+2.9%
$0.71vs$0.69
Q4 24
+4.2%
$0.74vs$0.71
Q1 25
+80.5%
$0.74vs$0.41
Q2 25
0.0%
$0.75vs$0.75
Q3 25
+2.7%
$0.77vs$0.75
Q4 25
+2.6%
$0.79vs$0.77
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.79 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.77 | $0.79 | +2.6% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $0.75 | $0.77 | +2.7% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $0.75 | $0.75 | 0.0% | = MET |
Q1 2025 | Feb 5, 2025 | $0.41 | $0.74 | +80.5% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.71 | $0.74 | +4.2% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.69 | $0.71 | +2.9% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.65 | $0.68 | +4.6% | ✓ BEAT |
Q1 2024 | Feb 7, 2024 | $0.67 | $0.68 | +1.5% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.70 | $0.71 | +1.4% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $0.69 | $0.74 | +7.2% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.60 | $0.66 | +10.0% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $0.73 | $0.73 | 0.0% | = MET |
Q4 2022 | Nov 2, 2022 | $0.77 | $0.76 | -1.3% | ✗ MISS |
Q3 2022 | Aug 1, 2022 | $0.76 | $0.76 | 0.0% | = MET |
Q2 2022 | May 2, 2022 | $0.32 | $0.79 | +146.9% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $0.82 | $0.77 | -6.1% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | $0.82 | $0.85 | +3.7% | ✓ BEAT |
Q3 2021 | Aug 2, 2021 | $0.83 | $0.85 | +2.4% | ✓ BEAT |
Latest News
Truist Securities Maintains Hold on Omega Healthcare Invts, Raises Price Target to $46
📈 PositiveBenzinga•Dec 2, 2025, 04:26 PM
Wells Fargo Maintains Overweight on Omega Healthcare Invts, Raises Price Target to $48
📈 PositiveBenzinga•Nov 25, 2025, 05:03 PM•Also:
UBS Initiates Coverage On Omega Healthcare Invts with Buy Rating, Announces Price Target of $50
📈 PositiveBenzinga•Nov 18, 2025, 12:38 PM•Also:
Scotiabank Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $45
📈 PositiveBenzinga•Nov 13, 2025, 05:50 PM
Citigroup Maintains Buy on Omega Healthcare Invts, Raises Price Target to $50
📈 PositiveBenzinga•Nov 12, 2025, 08:59 PM•Also:
Omega Healthcare Investors Form4 Filing Shows CEO Taylor C Pickett Bought 20,000 Shares At An Average Price Of $43.14/Share
📈 PositiveBenzinga•Nov 6, 2025, 10:03 PM
RBC Capital Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $44
➖ NeutralBenzinga•Nov 6, 2025, 04:23 PM
Omega Healthcare Investors shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 FFO guidance above estimates.
📈 PositiveBenzinga•Oct 31, 2025, 05:05 PM
Omega Healthcare Invts Raises FY2025 FFO Guidance from $3.04-$3.07 to $3.08-$3.10 vs $3.02 Est
📈 PositiveBenzinga•Oct 30, 2025, 08:16 PM
Omega Healthcare Invts Q3 FFO $0.79 Beats $0.76 Estimate, Sales $311.591M Beat $304.912M Estimate
📈 PositiveBenzinga•Oct 30, 2025, 08:16 PM
Omega Healthcare's Q3 earnings estimated to benefit stock, dividends
📈 PositiveSeeking Alpha•Oct 29, 2025, 05:17 PM
Wells Fargo Maintains Overweight on Omega Healthcare Invts, Raises Price Target to $45
📈 PositiveBenzinga•Oct 21, 2025, 01:17 PM
Cantor Fitzgerald Initiates Coverage On Omega Healthcare Invts with Overweight Rating, Announces Price Target of $50
📈 PositiveBenzinga•Oct 1, 2025, 01:53 PM
Mizuho Maintains Neutral on Omega Healthcare Invts, Raises Price Target to $40
➖ NeutralBenzinga•Sep 11, 2025, 01:25 PM
Truist Securities Maintains Hold on Omega Healthcare Invts, Raises Price Target to $44
➖ NeutralBenzinga•Sep 3, 2025, 12:38 PM
Scotiabank Maintains Sector Perform on Omega Healthcare Invts, Raises Price Target to $42
📈 PositiveBenzinga•Aug 28, 2025, 04:29 PM
Wells Fargo Maintains Overweight on Omega Healthcare Invts, Raises Price Target to $44
📈 PositiveBenzinga•Aug 27, 2025, 02:02 PM
Omega Healthcare Investors Backs MedaSync To Accelerate Growth Of AI-Powered Reimbursement Software For Skilled Nursing
📈 PositiveBenzinga•Aug 27, 2025, 01:07 PM
Omega Healthcare snaps extended sessions of gains
➖ NeutralSeeking Alpha•Jun 6, 2025, 08:11 PM
Omega Healthcare Investors snaps six straight sessions of losses
📈 PositiveSeeking Alpha•May 9, 2025, 08:06 PM
Frequently Asked Questions about OHI
What is OHI's current stock price?
Omega Healthcare Investors, Inc. (OHI) is currently trading at $43.97 per share. The stock has moved -1.21% today.
What is the analyst price target for OHI?
The average analyst price target for OHI is $46.80, based on 1 analyst.
What sector is Omega Healthcare Investors, Inc. in?
Omega Healthcare Investors, Inc. operates in the Real Estate sector, specifically within the REIT - Healthcare Facilities industry. The company is traded on the NYSE exchange.
What is OHI's market cap?
Omega Healthcare Investors, Inc. has a market capitalization of $12.99 billion, making it a large-cap company.
Does OHI pay dividends?
No, Omega Healthcare Investors, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Real Estate SectorAMH
American Homes 4 Rent
$31.12
Mkt Cap: $11.5B
DOC
Healthpeak Properties, Inc.
$15.99
Mkt Cap: $11.1B
ELS
Equity LifeStyle Properties, Inc.
$61.28
Mkt Cap: $11.9B
GLPI
Gaming and Leisure Properties, Inc.
$44.67
Mkt Cap: $12.6B
KIM
Kimco Realty Corporation
$19.99
Mkt Cap: $13.5B
LAMR
Lamar Advertising Company
$127.31
Mkt Cap: $12.9B
NLY
Annaly Capital Management, Inc.
$22.70
Mkt Cap: $13.8B
REG
Regency Centers Corporation
$68.55
Mkt Cap: $12.4B
RITM
Rithm Capital Corp.
$11.17
Mkt Cap: $5.9B
Explore stocks similar to OHI for comparison